This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Understanding what not to do when saving for retirement in your 30s can prevent costly mistakes. Educate yourself for a successful financial journey.
26,593 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Peabody Energy shares fell nearly 6% after a quarterly report that missed profitability targets. This article breaks ...
In May, nano nuclear energy powered stocks surged as collaborations with data centers and regulatory progress lifted ...
Investors are buzzing about a potential shift in how Rocket Lab does business. This article delves into what a SpaceX...
You’ve got $1,500 to invest for a three-year horizon. This guide compares XRP and Cardano, weighing risk, potential u...
A high-profile Nvidia deal has propelled a semiconductor stock into the spotlight. This article breaks down whether t...
A dramatic May surge can lure investors, but this glorious growth stock may face headwinds in June. This guide explai...
AeroVironment recently reported earnings that caught the market off guard in a good way. This article breaks down wha...
A big-name investment fund backed an IoT stock with a $20 million stake last quarter. Since then, the stock has tumbl...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
Missed the AI rally? Reasons watch MercadoLibre now. This guide breaks down three actionable catalysts, real-world sc...
A looked-at moment in media power and money: how a public challenge can ripple into legal fees, PR costs, and real-wo...